Vivani Medical Raises $4.5M in Registered Direct Offering and Private Placement

Vivani Medical has closed a registered direct offering and private placement of common stock, raising approximately $4.5 million. The company plans to use the funds for ongoing research and clinical development of its product candidates. Vivani develops miniature, ultra long-acting drug implants using its proprietary NanoPortal platform. The offering was priced "at-the-market" under Nasdaq rules and was led by ThinkEquity as sole placement agent.